Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 4 de 4
1.
Antivir Ther ; 29(3): 13596535241259952, 2024 Jun.
Article En | MEDLINE | ID: mdl-38873947

Angiotensin-converting enzyme 2 (ACE2) is the receptor that enables SARS-CoV-2 to invade host cells. Previous studies have reported that reducing ACE2 expression may have an anti-SARS-CoV-2 effect. In this study, we constructed a pGL4.10-F2-ACE2 vector with double luciferase genes (firefly and Renilla luciferase) under the control of the ACE2 promoter and used it to screen compounds from Chinese traditional medicinal herbs (CTMHs) that can inhibit ACE2 transcription in human cells. We transfected HEK293T cells with pGL4.10-F2-ACE2 and treated them with CTMH compounds and then measured fluorescence to evaluate the indirect inhibition of ACE2 transcription. Out of 37 compounds tested, andrographolide demonstrated a dose-dependent inhibition of ACE2 transcription. We further confirmed by RT-qPCR and Western blot assays that andrographolide also reduced ACE2 expression in BEAS-2B cells in a dose-dependent manner. Moreover, pseudovirus infection assays in BEAS-2B cells demonstrated that andrographolide can inhibit SARS-CoV-2 infection in a dose-dependent manner. These results suggest that andrographolide has potential anti-SARS-CoV-2 activity and could be a candidate drug for COVID-19 prevention and treatment.


Angiotensin-Converting Enzyme 2 , COVID-19 Drug Treatment , Diterpenes , Down-Regulation , SARS-CoV-2 , Humans , Diterpenes/pharmacology , Angiotensin-Converting Enzyme 2/genetics , Angiotensin-Converting Enzyme 2/metabolism , SARS-CoV-2/drug effects , SARS-CoV-2/genetics , HEK293 Cells , Down-Regulation/drug effects , COVID-19/virology , Antiviral Agents/pharmacology , Drugs, Chinese Herbal/pharmacology
2.
Am J Chin Med ; 51(5): 1189-1209, 2023.
Article En | MEDLINE | ID: mdl-37314412

HIV mutations occur frequently despite the substantial success of combination antiretroviral therapy, which significantly impairs HIV progression. Failure to develop specific vaccines, the occurrence of drug-resistant strains, and the high incidence of adverse effects due to combination antiviral therapy regimens call for novel and safer antivirals. Natural products are an important source of new anti-infective agents. For instance, curcumin inhibits HIV and inflammation in cell culture assays. Curcumin, the principal constituent of the dried rhizomes of Curcuma longa L. (turmeric), is known as a strong anti-oxidant and anti-inflammatory agent with different pharmacological effects. This work aims to assess curcumin's inhibitory effects on HIV in vitro and to explore the underpinning mechanism, focusing on CCR5 and the transcription factor forkhead box protein P3 (FOXP3). First, curcumin and the RT inhibitor zidovudine (AZT) were evaluated for their inhibitory properties. HIV-1 pseudovirus infectivity was determined by green fluorescence and luciferase activity measurements in HEK293T cells. AZT was used as a positive control that inhibited HIV-1 pseudoviruses dose-dependently, with IC50 values in the nanomolar range. Then, a molecular docking analysis was carried out to assess the binding affinities of curcumin for CCR5 and HIV-1 RNase H/RT. The anti-HIV activity assay showed that curcumin inhibited HIV-1 infection, and the molecular docking analysis revealed equilibrium dissociation constants of [Formula: see text]9.8[Formula: see text]kcal/mol and [Formula: see text]9.3[Formula: see text]kcal/mol between curcumin and CCR5 and HIV-1 RNase H/RT, respectively. To examine curcumin's anti-HIV effect and its mechanism in vitro, cell cytotoxicity, transcriptome sequencing, and CCR5 and FOXP3 amounts were assessed at different concentrations of curcumin. In addition, human CCR5 promoter deletion constructs and the FOXP3 expression plasmid pRP-FOXP3 (with an EGFP tag) were generated. Whether FOXP3 DNA binding to the CCR5 promoter was blunted by curcumin was examined using transfection assays employing truncated CCR5 gene promoter constructs, a luciferase reporter assay, and a chromatin immunoprecipitation (ChIP) assay. Furthermore, micromolar concentrations of curcumin inactivated the nuclear transcription factor FOXP3, which resulted in decreased expression of CCR5 in Jurkat cells. Moreover, curcumin inhibited PI3K-AKT activation and its downstream target FOXP3. These findings provide mechanistic evidence encouraging further assessment of curcumin as a dietary agent used to reduce the virulence of CCR5-tropic HIV-1. Curcumin-mediated FOXP3 degradation was also reflected in its functions, namely, CCR5 promoter transactivation and HIV-1 virion production. Furthermore, curcumin inhibition of CCR5 and HIV-1 might constitute a potential therapeutic strategy for reducing HIV progression.


Curcumin , HIV Infections , HIV-1 , Humans , Curcumin/pharmacology , Curcumin/chemistry , Curcuma/chemistry , HIV-1/genetics , HIV-1/metabolism , HEK293 Cells , Molecular Docking Simulation , Phosphatidylinositol 3-Kinases , Chemokines , HIV Infections/drug therapy , HIV Infections/genetics , Luciferases , Ribonuclease H/pharmacology , Forkhead Transcription Factors/pharmacology , Receptors, CCR5/genetics , Receptors, CCR5/metabolism
3.
ACS Appl Mater Interfaces ; 13(20): 23655-23661, 2021 May 26.
Article En | MEDLINE | ID: mdl-33980012

An unsupported nanoporous platinum-iron bimetallic catalyst (PtFeNPore) was prepared with an electrochemical dealloying technique. Its structure and composition were characterized through various measurement methods, such as X-ray absorption fine structure (XAFS) and X-ray photoelectron spectroscopy (XPS). An intermetallic compound and iron oxide species were both found in the PtFeNPore catalyst. The nanoporous structure and Lewis acidity (caused by iron oxide species) of the PtFeNPore catalyst resulted in superior catalytic activity and high selectivity. The PtFeNPore-catalyzed hydrogenation of various halonitrobenzenes proceeded successfully under mild reaction conditions and produced good to excellent yields of the corresponding haloanilines with high selectivity. PtFeNPore can be recycled through magnetic separation easily and reused five times without significant deactivation.

4.
Environ Sci Pollut Res Int ; 27(15): 18810-18821, 2020 May.
Article En | MEDLINE | ID: mdl-32207015

To enhance the generation of hydrogen peroxide (H2O2), a modified graphite felt cathode doped with nitrogen and boron was developed and used in peroxi-coagulation system to degrade dimethyl phthalate (DMP). After a simple modification method, the yield of H2O2 on cathode increased from 9.39 to 152.8 mg/L, with current efficiency increased from 1.61 to 70.3%. Complete degradation of DMP and 80% removal of TOC were achieved within 2 h at the optimal condition with pH of 5, cathodic potential of - 0.69 V (vs. SCE), oxygen aeration, and electrode gap of 1 cm. Possible mechanism with synergistic effect of electro-Fenton and electrocoagulation process in the peroxi-coagulation system was revealed via quenching experiments. The prospect of this system in the effluent of landfill leachate and domestic sewage was studied, achieving 50% and 61% of DMP removal in 2 h. This efficient system with simple modified cathode had promising prospects in practical applications.


Graphite , Water Pollutants, Chemical , Boron , Electrodes , Hydrogen Peroxide , Iron , Nitrogen , Oxidation-Reduction , Phthalic Acids
...